Role of NS1 antibodies in the pathogenesis of acute dengue infection
Authors:
- Deshni JayathilakaDJDeshni Jayathilaka
- Laksiri GomesLGLaksiri Gomes
- Chandima JeewandaraCJChandima Jeewandara
- Geethal S. Bandara JayerathneGJGeethal S. Bandara Jayerathne
- Dhanushka HerathDHDhanushka Herath
- Pathum Asela PereraPPPathum Asela Perera
- Samitha FernandoSFSamitha Fernando
- Ananda WijewickramaAWAnanda Wijewickrama
- Clare S. HardmanCHClare S. Hardman
- Graham S. OggGOGraham S. Ogg
- Gathsaurie Neelika MalavigeGMGathsaurie Neelika Malavige
Preprint
Abstract
The role of NS1-specific antibodies in the pathogenesis of dengue virus infection is of particular interest to the dengue field, yet remains poorly understood. We therefore investigated the immunoglobulin responses of patients with dengue fever (DF) and dengue hemorrhagic fever (DHF) to NS1. Antibody responses to recombinant-NS1 were assessed in serum samples obtained throughout illness of patients with acute secondary DENV1 and DENV2 infection by ELISA. NS1 antibody titres were significantly higher in patients with DHF compared to those with DF for both serotypes, during the critical phase of illness. Antibody responses were further assessed to NS1 peptides and showed that in both acute secondary DENV1 and DENV2 infection, the antibody repertoire of DF and DHF patients is directed towards distinct regions of the NS1 protein. Further experiments in healthy individuals, with either past severe dengue or past asymptomatic dengue infection revealed that individuals with past inapparent disease mounted antibody responses directed to the same NS1 epitope regions as those with mild acute infection (DF). Our results suggest that the specific epitope target of NS1-antibodies generated by patients could predict disease severity and be of potential therapeutic benefit in aiding vaccine and treatment design.Keywords
All Related Versions
- Published version: Nature Communications, 9 (1), 1.
This publication has 42 references indexed in Scilit:
- Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx componentsPLOS Pathogens, 2017
- Pathogenesis of vascular leak in dengue virus infectionImmunology, 2017
- Secreted NS1 Protects Dengue Virus from Mannose-Binding Lectin–Mediated NeutralizationThe Journal of Immunology, 2016
- Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrityScience Translational Medicine, 2015
- Recognition determinants of broadly neutralizing human antibodies against dengue virusesNature, 2015
- Dengue NS1 antigen as a marker of severe clinical diseaseBMC Infectious Diseases, 2014
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trialThe Lancet, 2014
- The flavivirus NS1 protein: Molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarkerAntiviral Research, 2013
- The global distribution and burden of dengueNature, 2013
- Antibodies from dengue patient sera cross‐react with endothelial cells and induce damageJournal of Medical Virology, 2002